ImmunoPrecise Antibodies Ltd (NAS:IPA)
$ 0.77 -0.0233 (-2.94%) Market Cap: 21.02 Mil Enterprise Value: 29.23 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 53/100

Q2 2024 Immunoprecise Antibodies Ltd Earnings Call Transcript

Dec 14, 2023 / 03:30PM GMT
Release Date Price: $1.45 (+20.83%)
Operator

Good morning, ladies and gentlemen. Thank you for joining us today for IPA's earnings call covering the second quarter of fiscal year 2024. I am Sarah, and I have the privilege of hosting this call.

Before we commence, I would like to draw your attention to the fact that our discussion today may include forward-looking statements. These statements are subject to various risks and uncertainties that could cause actual results to differ materially from what we express or imply. We strongly encourage you to review our filings with the Securities and Exchange Commission for a comprehensive discussion of these risks and uncertainties. IPA remains committed to complying with legal requirements and will update forward-looking statements only as mandated by law.

During today's conference call as well as in the accompanying presentation slides, we will be employing non-GAAP financial measures to assist investors and analysts in comprehending IPA's business performance. Adjusted EBITDA in particular allows for meaningful comparisons and analysts' analysis of trends in our business over different

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot